4 results found
Mantis Biotech has secured $7.4 million in seed funding to advance its platform for creating 'digital twins' of humans. These physics-based, predictive models aim to solve the critical data availability issues in biomedical research, especially for rare diseases, by generating synthetic datasets. Currently, Mantis is applying its technology in professional sports to predict athlete performance and injury, with plans to expand into preventative healthcare and pharmaceutical research.
Europe's tech sector saw over $1.1 billion in funding and fund closes from March 23-29, with significant investments flowing into deep tech, AI infrastructure, and a diverse range of sectors including biotech, space, and defense. This highlights a strategic continental focus on foundational innovations and long-term technological advancements.
Utrecht, Netherlands – Laigo Bio, a pioneering Dutch biotech firm, has successfully concluded an oversubscribed €17 million seed funding round. The substantial capital infusion, which saw an additional €5.5 million
Billionaire-backed startup R3 Bio is developing genetically-engineered, nonsentient "organ sacks" to replace animal testing. This initiative aligns with the Trump administration's efforts to phase out animal experimentation, offering a potentially humane and effective alternative for scientific research. The company aims to eventually create human versions for personalized medical testing.
